ARL17 anticorps (Middle Region)
-
- Antigène Voir toutes ARL17 Anticorps
- ARL17 (ADP-Ribosylation Factor-Like 17B (ARL17))
- Épitope
- Middle Region
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ARL17 est non-conjugé
- Application
- Western Blotting (WB)
- Specificité
- ARL17 antibody was raised against the middle region of ARL17
- Purification
- Affinity purified
- Immunogène
- ARL17 antibody was raised using the middle region of ARL17 corresponding to a region with amino acids KCSHVEFGMWKGGRSHPFLPHSSRCAGSGGQLDSILPHQSPAWGPWGCKD
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
ARL17 Blocking Peptide, catalog no. 33R-4276, is also available for use as a blocking control in assays to test for specificity of this ARL17 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ARL17 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- ARL17 (ADP-Ribosylation Factor-Like 17B (ARL17))
- Autre désignation
- ARL17 (ARL17 Produits)
- Synonymes
- anticorps ARL17, anticorps ARL17A, anticorps ADP ribosylation factor like GTPase 17B, anticorps ARL17B
- Sujet
- ARL17 is a GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. ARL17 is involved in protein trafficking, may modulate vesicle budding and uncoating within the Golgi apparatus.
- Poids moléculaire
- 19 kDa (MW of target protein)
-